The epidemiology of Plasmodium falciparum gametocytes: weapons of mass dispersion

Trends in Parasitology

Volumn 22, Issue 9, 2006, Pages 424-430

  Drakeley, Chris ^a   Sutherland, Colin ^a   Bousema, J Teun ^b   Sauerwein, Robert W ^b   Targett, Geoffrey A T ^a  

^a LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^b RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

8 AMINOQUINOLINE DERIVATIVE; ARTEMISININ; PYRIMETHAMINE; SULFADOXINE;

ASEXUAL REPRODUCTION; CYTOLOGY; DRUG EFFICACY; DRUG TARGETING; DRUG TREATMENT FAILURE; EPIDEMIOLOGICAL DATA; EVIDENCE BASED MEDICINE; GAMETOCYTE; GAMETOGENESIS; GROUPS BY AGE; HUMAN; INFECTION CONTROL; INFECTION PREVENTION; MALARIA; MOSQUITO; NONHUMAN; PARASITE IMMUNITY; PARASITE TRANSMISSION; PARASITE VECTOR; PLASMODIUM FALCIPARUM; PREVALENCE; REVIEW; SEASONAL VARIATION;

ADOLESCENT; ADULT; AGE FACTORS; ANIMALS; ANOPHELES; CARRIER STATE; CHILD; CHILD, PRESCHOOL; HUMANS; IMMUNITY, NATURAL; INFANT; INSECT VECTORS; MALARIA, FALCIPARUM; PARASITE EGG COUNT; PLASMODIUM FALCIPARUM; PREVALENCE; SEASONS;

PLASMODIUM FALCIPARUM;

EID: 33746845316     PISSN: 14714922     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pt.2006.07.001     Document Type: Review

References (71)

1. Baton L.A., and Ranford-Cartwright L.C. Spreading the seeds of million-murdering death: metamorphoses of malaria in the mosquito. Trends Parasitol. 21 (2005) 573-580
2. Greenwood B.M. Asymptomatic malaria infections-do they matter?. Parasitol. Today 3 (1987) 206-214
3. Drakeley C.J., et al. Altitude-dependent and -independent variations in Plasmodium falciparum prevalence in Northeastern Tanzania. J. Infect. Dis. 191 (2005) 1589-1598
4. Macdonald G. Community aspects of immunity to malaria. Br. Med. Bull. 8 (1951) 33-36
5. Molineaux L., and Gramiccia G. The Garki Project. Research on the epidemiology and control of malaria in the Sudan savannah of West Africa (1980), WHO
6. Nedelman J. Gametoctaemia and Infectiousness in Falciparum malaria: Observations and Models. Adv. Dis. Vector Res. 6 (1989) 59-89
7. Mwangi T.W., et al. Clinical algorithms for malaria diagnosis lack utility among people of different age groups. Trop. Med. Int. Health 10 (2005) 530-536
8. Wilson D. Rural hyper-endemic malaria in Tanganyika territory. Trans. R. Soc. Trop. Med. Hyg. 29 (1936) 583-618
9. Drakeley C.J., et al. Estimates of the infectious reservoir of Plasmodium falciparum malaria in The Gambia and in Tanzania. Trans. R. Soc. Trop. Med. Hyg. 94 (2000) 472-476
10. Abdel-Wahab A., et al. Dynamics of gametocytes among Plasmodium falciparum clones in natural infections in an area of highly seasonal transmission. J. Infect. Dis. 185 (2002) 1838-1842
11. Paul R.E., et al. Mosquitoes and transmission of malaria parasites - not just vectors. Malar. J. 3 (2004) 39
12. Nacher M., et al. Seasonal variation in hyperparasitaemia and gametocyte carriage in patients with Plasmodium falciparum malaria on the Thai-Burmese border. Trans. R. Soc. Trop. Med. Hyg. 98 (2004) 322-328
13. von Seidlein L., et al. Parasitaemia and gametocytaemia after treatment with chloroquine, pyrimethamine/sulfadoxine, and pyrimethamine/sulfadoxine combined with artesunate in young Gambians with uncomplicated malaria. Trop. Med. Int. Health 6 (2001) 92-98
14. Alves F.P., et al. Asymptomatic carriers of Plasmodium spp. as infection source for malaria vector mosquitoes in the Brazilian Amazon. J. Med. Entomol. 42 (2005) 777-779
15. Miller M.J. Observations on the natural history of malaria in the semi-resistant West African. Trans. R. Soc. Trop. Med. Hyg. 52 (1958) 152-168
16. Jeffery G.M., and Eyles D.E. Infectivity to mosquitoes of Plasmodium falciparum as related to gametocyte density and duration of infection. Am. J. Trop. Med. Hyg. 4 (1955) 781-789
17. Drakeley C.J., et al. Plasmodium falciparum gametocytes in Gambian adults. Ann. Trop. Med. Parasitol. 94 (2000) 399-401
18. Bousema J.T., et al. Plasmodium falciparum gametocyte carriage in asymptomatic children in western Kenya. Malar. J. 3 (2004) 18
19. Meerman L., et al. Carriage of chloroquine-resistant parasites and delay of effective treatment increase the risk of severe malaria in Gambian children. J. Infect. Dis. 192 (2005) 1651-1657
20. Akim N.I., et al. Dynamics of P. falciparum gametocytemia in symptomatic patients in an area of intense perennial transmission in Tanzania. Am. J. Trop. Med. Hyg. 63 (2000) 199-203
21. Price R., et al. Risk factors for gametocyte carriage in uncomplicated falciparum malaria. Am. J. Trop. Med. Hyg. 60 (1999) 1019-1023
22. Paul R.E., et al. Plasmodium sex determination and transmission to mosquitoes. Trends Parasitol. 18 (2002) 32-38
23. Talman A.M., et al. Gametocytogenesis: the puberty of Plasmodium falciparum. Malar. J. 3 (2004) 24
24. Smalley M.E., and Brown J. Plasmodium falciparum gametocytogenesis stimulated by lymphocytes and serum from infected Gambian children. Trans. R. Soc. Trop. Med. Hyg. 75 (1981) 316-317
25. Nacher M., et al. Decreased hemoglobin concentrations, hyperparasitemia, and severe malaria are associated with increased Plasmodium falciparum gametocyte carriage. J. Parasitol. 88 (2002) 97-101
26. Trager W. What triggers the gametocyte pathway in Plasmodium falciparum?. Trends Parasitol. 21 (2005) 262-264
27. Targett G., et al. Artesunate reduces but does not prevent posttreatment transmission of Plasmodium falciparum to Anopheles gambiae. J. Infect. Dis. 183 (2001) 1254-1259
28. Schneider P., et al. Quantification of Plasmodium falciparum gametocytes in differential stages of development by quantitative nucleic acid sequence-based amplification. Mol. Biochem. Parasitol. 137 (2004) 35-41
29. Barnes K.I., and White N.J. Population biology and antimalarial resistance: the transmission of antimalarial drug resistance in Plasmodium falciparum. Acta Trop. 94 (2005) 230-240
30. Graves P.M., et al. Gametocyte production in cloned lines of Plasmodium falciparum. Am. J. Trop. Med. Hyg. 33 (1984) 1045-1050
31. Eichner M., et al. Genesis, sequestration and survival of Plasmodium falciparum gametocytes: parameter estimates from fitting a model to malaria therapy data. Trans. R. Soc. Trop. Med. Hyg. 95 (2001) 497-501
32. Piper K.P., et al. Malaria transmission and naturally acquired immunity to PfEMP-1. Infect. Immun. 67 (1999) 6369-6374
33. Sharp, S. et al. Programmed transcription of the var gene family, but not of stevor, in Plasmodium falciparum gametocytes. Eukaryot. Cell (in press)
34. Ponnudurai T., et al. Cultivation of fertile Plasmodium falciparum gametocytes in semi-automated systems. 1. Static cultures. Trans. R. Soc. Trop. Med. Hyg. 76 (1982) 812-818
35. Naotunne T.S., et al. Cytokines kill malaria parasites during infection crisis: extracellular complementary factors are essential. J. Exp. Med. 173 (1991) 523-529
36. Ade-Serrano M.A., et al. Correlation of Plasmodium falciparum gametocytemia with complement component titers in rural Nigerian school children. J. Clin. Microbiol. 13 (1981) 195-198
37. Read D., et al. Transmission-blocking antibodies against multiple, non-variant target epitopes of the Plasmodium falciparum gamete surface antigen Pfs230 are all complement-fixing. Parasite Immunol. 16 (1994) 511-519
38. Adjuik M., et al. Artesunate combinations for treatment of malaria: meta-analysis. Lancet 363 (2004) 9-17
39. Butcher G.A. Antimalarial drugs and the mosquito transmission of Plasmodium. Int. J. Parasitol. 27 (1997) 975-987
40. Price R.N., et al. Effects of artemisinin derivatives on malaria transmissibility. Lancet 347 (1996) 1654-1658
41. Handunnetti S.M., et al. Features of recrudescent chloroquine-resistant Plasmodium falciparum infections confer a survival advantage on parasites and have implications for disease control. Trans. R. Soc. Trop. Med. Hyg. 90 (1996) 563-567
42. Drakeley C.J., et al. Addition of artesunate to chloroquine for treatment of Plasmodium falciparum malaria in Gambian children causes a significant but short-lived reduction in infectiousness for mosquitoes. Trop. Med. Int. Health 9 (2004) 53-61
43. Hallett R., et al. Chloroquine/sulphadoxine-pyrimethamine for uncomplicated malaria in Gambian children: enhanced transmission to mosquitoes of multi-drug-resistant Plasmodium falciparum. PLoS Clinical Trials 1 (2006) e15
44. Barnes K.I., et al. Effect of Artemether-lumefantrine policy and improved vector control on malaria burden in KwaZulu-Natal, South Africa. PLoS Med 2 (2005) e330
45. Bousema J.T., et al. Moderate effect of artemisinin-based combination therapy on transmission of Plasmodium falciparum. J. Infect. Dis. 193 (2006) 1151-1159
46. Rosenberg R., et al. Seasonal fluctuation of Plasmodium falciparum gametocytaemia. Trans. R. Soc. Trop. Med. Hyg. 84 (1990) 29-33
47. Cohen S., et al. Gamma-globulin and acquired immunity to human malaria. Nature 192 (1961) 733-737
48. Bousema J.T., et al. Sexual-stage antibody responses to P. falciparum in endemic populations. Curr. Mol. Med. 6 (2006) 223-229
49. Taylor L.H., and Read A.F. Why so few transmission stages? Reproductive restraint by malaria parasites. Parasitol. Today 13 (1997) 135-140
50. Baird J.K., et al. Evidence for specific suppression of gametocytemia by Plasmodium falciparum in residents of hyperendemic Irian Jaya. Am. J. Trop. Med. Hyg. 44 (1991) 183-190
51. McRobert L., et al. Distinct trafficking and localization of STEVOR proteins in three stages of the Plasmodium falciparum life cycle. Infect. Immun. 72 (2004) 6597-6602
52. Jeffery G.M. Epidemiological significance of repeated infections with homologous and heterologous strains and species of Plasmodium. Bull. World Health Organ. 35 (1966) 873-882
53. Carter R., and Graves P.M. Gametocytes. In: Wernsdorfer W.H., and McGregor I. (Eds). Malaria: Principles and Practice of Malariology (1988), Churchill Livingstone 253-305
54. Boudin C., et al. High human malarial infectivity to laboratory-bred Anopheles gambiae in a village in Burkina Faso. Am. J. Trop. Med. Hyg. 48 (1993) 700-706
55. Sutherland C.J., et al. Reduction of malaria transmission to Anopheles mosquitoes with a six-dose regimen of co-artemether. PLoS Med 2 (2005) e92
56. Muirhead-Thomson R.C. The malarial infectivity of an African village population to mosquitoes (Anopheles gambiae); a random xenodiagnostic survey. Am. J. Trop. Med. Hyg. 6 (1957) 971-979
57. Bonnet S., et al. Estimation of malaria transmission from humans to mosquitoes in two neighbouring villages in south Cameroon: evaluation and comparison of several indices. Trans. R. Soc. Trop. Med. Hyg. 97 (2003) 53-59
58. Githeko A.K., et al. The reservoir of Plasmodium falciparum malaria in a holoendemic area of western Kenya. Trans. R. Soc. Trop. Med. Hyg. 86 (1992) 355-358
59. Killeen, G. et al. Infectivity of Plasmodium falciparum infected humans to mosquitoes. Am. J. Trop. Med. Hyg. (in press)
60. Carter R., et al. Malaria transmission-blocking vaccines-how can their development be supported?. Nat. Med. 6 (2000) 241-244
61. von Seidlein L., and Greenwood B.M. Mass administrations of antimalarial drugs. Trends Parasitol. 19 (2003) 452-460
62. Metselaar D. Relative increase in the prevalence of Plasmodium falciparum some years after the beginning of a house-spraying campaign in Netherlands New Guinea. Trans. R. Soc. Trop. Med. Hyg. 54 (1960) 523-528
63. John C.C., et al. Low prevalence of Plasmodium falciparum infection among asymptomatic individuals in a highland area of Kenya. Trans. R. Soc. Trop. Med. Hyg. 99 (2005) 780-786
64. Schellenberg D., et al. Intermittent preventive antimalarial treatment for Tanzanian infants: follow-up to age 2 years of a randomised, placebo-controlled trial. Lancet 365 (2005) 1481-1483
65. Colbourne M.J. The effect of prolonged examination of bloodfilms on the parasite rate. West Afr. Med. J. 5 (1956) 26-30
66. Dowling M.A., and Shute G.T. A comparative study of thick and thin blood films in the diagnosis of scanty malaria parasitaemia. Bull. World Health Organ. 34 (1966) 249-267
67. Mulder B., et al. Detection of Plasmodium falciparum gametocytes with the OBC test and Giemsa-stained thick blood films for malaria transmission studies in Cameroon. Trans. R. Soc. Trop. Med. Hyg. 92 (1998) 395-396
68. WHO (2006) Guidelines for the treatment of malaria. pp. 8-10, WHO
69. Kachur S.P., et al. Adherence to antimalarial combination therapy with sulfadoxine-pyrimethamine and artesunate in rural Tanzania. Am. J. Trop. Med. Hyg. 71 (2004) 715-722
70. Gouagna L.C., et al. Plasmodium falciparum malaria disease manifestations in humans and transmission to Anopheles gambiae: a field study in Western Kenya. Parasitology 128 (2004) 235-243
71. Cisse B., et al. Seasonal intermittent preventive treatment with artesunate and sulfadoxine-pyrimethamine for prevention of malaria in Senegalese children: a randomised, placebo-controlled, double-blind trial. Lancet 367 (2006) 659-667